ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Triethylamine → (R)-Tert-butyl 3-(5-(benzo[d]thiazol-2-yl)-6-methoxy-2-morpholinopyrimidin-4-ylamino)piperidine-1-carboxylate

HRID 1507490
印刷

反応式

HRID 1507490 の反応式
C([Sn](CCCC)(CCCC)[C:6]1[S:7][C:8]2[CH:14]=[CH:13][CH:12]=[CH:11][C:9]=2[N:10]=1)CCC.I[C:24]1[C:25]([NH:38][C@@H:39]2[CH2:44][CH2:43][CH2:42][N:41]([C:45]([O:47][C:48]([CH3:51])([CH3:50])[CH3:49])=[O:46])[CH2:40]2)=[N:26][C:27]([N:32]2[CH2:37][CH2:36][O:35][CH2:34][CH2:33]2)=[N:28][C:29]=1[O:30][CH3:31].CCN(CC)CC>C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.[Cu]I.O1CCOCC1>[S:7]1[C:8]2[CH:14]=[CH:13][CH:12]=[CH:11][C:9]=2[N:10]=[C:6]1[C:24]1[C:25]([NH:38][C@@H:39]2[CH2:44][CH2:43][CH2:42][N:41]([C:45]([O:47][C:48]([CH3:51])([CH3:50])[CH3:49])=[O:46])[CH2:40]2)=[N:26][C:27]([N:32]2[CH2:33][CH2:34][O:35][CH2:36][CH2:37]2)=[N:28][C:29]=1[O:30][CH3:31]
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 3

HCID 8471TriethylamineHCID 37623922-(Tributylstannyl)-1,3-benzothiazoleHCID 89554305(R)-Tert-butyl 3-(5-iodo-6-methoxy-2-morpholinopyrimidin-4-ylamino)piperidine-1-carboxylate

生成物 1

HCID 117677739(R)-Tert-butyl 3-(5-(benzo[d]thiazol-2-yl)-6-methoxy-2-morpholinopyrimidin-4-ylamino)piperidine-1-carboxylate

試薬・触媒・溶媒 3

HCID 24350
Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)
触媒
HCID 178418397HCID 178418397、化合物触媒
HCID 312751,4-Dioxane溶媒

実験手順

2-Tributylstannylbenzothiazole (221 mg, 0.520 mmol), Compound 21 (150 mg, 0.289 mmol), Tetrakis(triphenylphosphine)palladium (67 mg, 0.0578 mmol), and CuI (11 mg, 0.0578 mmol) were combined. Dioxane (4 mL) was added followed by Et3N (161 μL, 1.16 mmol) and the mixture was degassed and heated to reflux for 2 h. The solution was cooled to room temperature and an aqueous 10% KF solution was added and the mixture was stirred for 30 min. The mixture was diluted with EtOAc and washed with water, brine, dried (MgSO4), filtered and evaporated to dryness. The residue was purified by column chromatography on silica gel, eluting with EtOAc/hexane to give the title compound as a yellow solid. 1H NMR (CDCl3) δ 10.74 (br s, 1H), 7.86-7.82 (m, 2H), 7.41 (t, J=7.2 Hz, 1H), 7.27 (t, J=7.2 Hz, 1H), 4.25 (br s, 1H), 4.09 (s, 3H), 3.87 (br s, 4H), 3.78-3.76 (m, 4H), 3.52 (br s, 4H), 2.03 (br s, 1H), 1.90 (br s, 1H), 1.76-1.73 (m, 1H), 1.66-1.64 (m, 1H), 1.33 (s, 9H); LCMS 3.28 min, 527 (M+H).

後処理

  1. customthe mixture was degassed
  2. temperatureheated
  3. temperatureto reflux for 2 h
  4. additionan aqueous 10% KF solution was added
  5. additionThe mixture was diluted with EtOAc
  6. washwashed with water, brine
  7. dry with materialdried (MgSO4)
  8. filtrationfiltered
  9. customevaporated to dryness
  10. customThe residue was purified by column chromatography on silica gel
  11. washeluting with EtOAc/hexane

出典と根拠

ORDレコード
ord-f3ba5e00051c4a44ad68305e51813289
出典データセット
uspto-grants-2015_12
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09221809B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート